- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Remus Pharmaceuticals Limited — Important, 17-05-2025: General Updates
17-05-2025 | 06:57 pm
17-05-2025 | 06:57 pm
Remus Pharmaceuticals has announced a board meeting to appoint Sharp & Tannan Associates as internal auditor for FY 2025-26. The firm’s expertise in risk-based auditing and automation via robotics process automation aims to boost audit quality and operational efficiency, supporting stronger internal controls and process optimization.
No comments yet. Be the first to comment!